Trials / Completed
CompletedNCT04260321
The AID Study 2: Artificial Intelligence for Colorectal Adenoma Detection 2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (actual)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Colonoscopy is clinically used as the gold standard for detection of colon cancer (CRC) and removal of adenomatous polyps. Despite the success of colonoscopy in reducing cancer-related deaths, there exists a disappointing level of adenomas missed at colonoscopy. "Back-to-back" colonoscopies have indicated significant miss rates of 27% for small adenomas (\< 5 mm) and 6% for adenomas of more than 10 mm in diameter. Studies performing both CT colonography and colonoscopy estimate that the colonoscopy miss rate for polyps over 10 mm in size may be as high as 12%. The clinical importance of missed lesions should be emphasized because these lesions may ultimately progress to CRC. Limitations in human visual perception and other human biases such as fatigue, distraction, level of alertness during examination increases such recognition errors and way of mitigating them may be the key to improve polyp detection and further reduction in mortality from CRC. In the past years, a number of CAD systems for detection of polyps from endoscopy images have been described. However, the benefits of traditional CAD technologies in colonoscopy appear to be contradictory, therefore they should be improved to be ultimately considered useful. Recent advances in artificial intelligence (AI), deep learning (DL), and computer vision have shown potential to assist polyp detection during colonoscopy. Average experienced endoscopists (each having performed \<2000 screening colonoscopies) will perform the endoscopic procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AI | Artificial intelligence colonoscopy |
Timeline
- Start date
- 2020-02-19
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2020-02-07
- Last updated
- 2021-02-05
Locations
5 sites across 2 countries: Italy, Switzerland
Source: ClinicalTrials.gov record NCT04260321. Inclusion in this directory is not an endorsement.